| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.22 | 0.0002 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.2 | 0.0005 |